Protozoa, such as Cryptosporidium parvum and Giardia lamblia, pose a human health risk when present in drinking water. To minimize health risks, the Nova Scotia Treatment Standards for surface water and groundwater under the direct influence of surface water require a 3-log reduction for Giardia cysts and Cryptosporidium oocysts. This study determined the protozoan risk of municipal surface source waters in Nova Scotia, through the use of a pre-screening risk analysis of water supplies, followed by subsequent water quality analysis of the seven highest risk supplies. The water supplies were monitored monthly for 1 year to obtain baseline data that could be used for a quantitative microbial risk assessment (QMRA). The QMRA model outcomes were compared to the Health Canada health target of 10 À6 disability-adjusted life years/person/year. QMRA modeling shows that the treatment facilities meet the required log reductions and disability-adjusted life year target standards under current conditions. Furthermore, based on the results of this work, Nova Scotia should maintain the current 3-log reduction standard for Giardia cysts and Cryptosporidium oocysts. The results of this study show that a pre-screening step can help to inform water sources that are particularly vulnerable to protozoan contamination, which can lead to more focused, costeffective sampling, and monitoring programs.
Within Nova Scotia, there are 82 municipal water sources, of which, 54% use surface water and another 12% use a combination of surface water and groundwater (Nova Scotia Environment (NSE) ). In general, the surface water in Nova Scotia is of high quality, with very little agricultural, industrial, wildlife, and human impacts upstream of source waters. A description of the source water for the largest plant in Nova Scotia has been provided elsewhere (Knowles et al. ) and is a useful example of the general characteristics of surface water in Nova Scotia.
In general, surface waters in Nova Scotia are characterized as low alkalinity, low turbidity waters (Waller et al. ) .
In Nova Scotia, an owner of a public drinking water supply must follow the Guidelines for Canadian Drinking Water Quality to ensure the provision of safe drinking water. In addition, the Nova Scotia Treatment Standards for surface water, or groundwater under the direct influence of surface water, requires the following for pathogen removal: filtration and disinfection to provide 3-log reduction for Giardia cysts and Cryptosporidium oocysts and 4-log reduction for viruses (NSE ). The 3-log removal of Cryptosporidium oocysts was added to the treatment standards in 2012.
Health Canada suggests the use of quantitative microbial risk analysis (QMRA) as part of a multi-barrier approach to better understand the risk related to a water system (Health Canada a). QMRA uses mathematical modeling combined with source water quality data, treatment barrier information, and pathogen-specific characteristics to estimate the burden of disease associated with pathogen exposure in a drinking water source (Health Canada a). To perform QMRA on a particular source, distributions of microbial presence (Escherichia coli or protozoa) from direct monitoring or assumed distributions are incorporated into the model, along with treatment performance factors to determine an overall risk of illness, effectiveness of treatment barriers, adequacy of existing control measures, and to evaluate system response to changes in microbial source water quality.
The level of risk given as an output from the QMRA model uses the concept of disability-adjusted life years (DALYs) (World Health Organization (WHO) ).
DALYs take into account the probability of experiencing an illness and the impact of the associated health effects (e.g., years lost due to mortality and number of years lived with a disability). Health Canada suggests adopting the World Health Organization (WHO) health target of 10 À6 DALYs/person/year (Health Canada a).
The objective of this study was to determine the protozoan risk of municipal surface water sources in Nova Scotia, in order to validate the incorporation of a 3-log reduction for Giardia cysts and Cryptosporidium oocysts in the Nova Scotia Treatment Standards. This was accomplished in three steps. First, a regulatory analysis was conducted to determine the protozoan monitoring/treatment standard approaches used in other jurisdictions to ensure that the standards are in line with other jurisdictions.
Second, a semi-quantitative risk analysis was used as a prescreening tool to determine the most vulnerable sites for protozoan presence in Nova Scotia surface source waters.
Finally, results from a 1-year monthly protozoan sampling program were used to provide inputs to a QMRA assessment to determine the human health risk posed by the identified highest risk water sources and their existing treatment processes.
were examined in the semi-quantitative risk analysis. Each risk was assigned a weighting factor based on the perceived contribution to overall contamination. These risk categories included: wastewater discharge, on-site septic wastewater, agricultural livestock, agricultural crops, and stormwater impacts. Within each of these risk categories, values between 0 and 5 were assigned for each source water based on the level of perceived risk; these are listed in Table 1 . The assigned risk values were multiplied by the weighting factor and then summed to give an overall relative risk value for each water source. The risk weightings and determination of values used a consistent approach for all surface source waters.
Source water sampling
The seven highest risk source waters, as determined by the pre-screening tool, were then used for further analysis of microbial risk through microbial water sampling. Five of these water sources were sampled monthly for protozoa and general water quality over a 1-year period. Samples were taken either from a raw water tap within the water 
Sample collection and analysis
For Cryptosporidium and Giardia, 10 L of water was filtered through the Pall Corporation's Envirochek™ HV 1.0 μm filter through use of a raw water tap where available. In situations where raw water taps were not available, >10 L was collected in a 20 L plastic jug and either filtered on-site using a mobile pump, or taken to the Dalhousie laboratory where it was processed accordingly. A 10 L sample was chosen for this study to be consistent with methodology used by the utility that provided results for Communities F and G from their monthly source water sampling program. The Enviro-chek™ filters were then placed on ice and shipped overnight to CEC laboratories in Vermont where they A 1 L amber glass bottle was filled headspace free with a sample for testing pH. pH was measured at the CWTL using an Accumet Excel XL50 Dual Channel pH/ion/conductivity meter with an Accumet pH probe calibrated daily using pH 4.0, 7.0, and 10.0 buffers from Fisher Scientific.
QMRA modeling
To determine whether the seven communities achieved the acceptable health-based reduction targets for protozoa and E. coli, QMRA was performed using a spreadsheet developed and provided by Health Canada.
For all communities, two different cases were modeled through QMRA to assess the health impacts due to the presence or absence of treatment barriers. For each site, all treatment barriers were assumed to be in place for Case 1.
For Case 2, it was assumed that no treatment barriers were in place, which would be akin to drinking untreated water.
To gather the data for QMRA analysis, the following information was collected from the seven communities: Several instances occurred where the actual treatment process used in a system was not an available input option in the QMRA model, and these had to be adjusted to comply with the model's treatment options. In Communities A and B, dissolved air flotation is used in the facility, but this had to be entered as 'coagulation, flocculation, sedimentation' in the model. In Communities F and G, both nanoand ultra-filtration membranes are used, but the only membranes included in the QMRA model are ultra-filtration membranes. Thus, these two communities have greater levels of filtration in their facilities, but the model could not capture this. These results are presented in Table 3 .
The minimum reduction requirement for Cryptosporidium also varies by jurisdiction, as shown in 
Nova Scotia surface water vulnerability assessment
The results of the Nova Scotia semi-quantitative risk analysis are presented in Table 5 . The source water for Community A was given the highest risk (112.5) value. 
Source water sampling
The results of monthly sampling (and/or utility data) at the seven surface water sources in Nova Scotia are presented in Table 6 . For the first month, only a presence/ absence test was done for total coliforms and E. coli.
The utility took monthly samples at these two sites for 2 years and all results are presented. Sample results for Cryptosporidium and Giardia in Table 6 are presented as cysts/100 L even though the detection limit was cysts/10 L. This was done to be consistent with the 
QMRA modeling
All seven systems assessed met NSE's 3-log reduction requirement for Cryptosporidium and Giardia when all treatment barriers were in place (Table 7) . Health
Canada recommends the use of 10 À6 DALYs/person/ year as an acceptable level of risk. Figure 1 place as shown in Figure 1 , noting that QMRA was only completed for systems that showed the presence of microbial parameters. For all seven systems, if all treatment barriers fail (i.e., raw water is consumed), all systems would fail the health target for the three microbes. Weight (10) Weight (5) Weight (7) Weight (6) Weight (2) Use of a surface water vulnerability assessment as a pre-screening tool
By comparing the risk ranking of the semi-quantitative risk analysis with the results of the microbial sampling (both concentration and number of positive samples), we end up with the following risk rankings for the source waters (not taking into consideration the treatment barriers) from high to low:
• source water for Communities G, C, B, A, F, D, E (water quality data);
• source water for Communities A, G, B, D, E, C, F (semiquantitative risk analysis).
The semi-quantitative risk analysis was a good first step toward identifying the water sources most at risk and prioritizing resources for source water monitoring. However, the differences in the bullet points demonstrate the importance for collecting actual samples from sources that may be at risk to truly assess source water quality and risk.
In this study, there was only one positive sample for Cryptosporidium, and 14 positive samples for Giardia.
Based on these results, Giardia appears to be the protozoa of concern in source waters in Nova Scotia. However, utili- Table 7 ).
In addition, three of the seven sites did not have sample results that indicated the need for a >3-log requirement for Giardia. It would then be likely that source waters with lower risk factors would also not require a >3-log reduction for protozoa, unless a major change occurred within the watershed increasing the risk of source water contamination.
CONCLUSIONS
Seven surface waters in Nova Scotia were evaluated for source water protozoan risks, all of which likely had the highest risk of microbial contamination in the province, based on a semi-quantitative risk analysis. The microbial sampling results in this study indicated that some source waters in Nova Scotia are at higher risk of contamination than the current 3-log reduction requirement in the province. The semi-quantitative risk analysis is a useful pre-screening tool for directing resources toward vulnerable source waters, but is not an adequate replacement for site sampling and analysis.
The majority of regulations across Canada and in the USA require 3-log reduction for Giardia and either 2-or 3log reduction for Cryptosporidium, unless source water protozoan concentrations dictate increased log reduction.
Based on the results from this study, it would appear that
Giardia is of larger concern in source waters in Nova Scotia than Cryptosporidium. Also, the frequent use of E. coli as an indicator organism for protozoa in small systems helps with cost reduction, but this study indicated that E. coli is not an appropriate indicator for protozoa in Nova Scotia.
Based on the results of this study, there is no justification to require greater than 3-log reduction for Giardia cysts or Cryptosporidium oocysts in Nova Scotia at this time. The QMRA demonstrated that existing conditions provided adequate health risk mitigation and the actual treatment reductions achieved were greater than 3-log.
This was made necessary because in some cases greater health targets were required for vulnerable source waters. If these facilities were only designed to achieve 3-log reduction of protozoa, they would not meet the health targets. The use of actual water quality data and treatment performance in the model is critical to ensure that results are reflective of actual practice and sitespecific conditions. 
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